In this work, we study various hybrid models of entropy-based and representativeness sampling techniques in the context of active learning in medical segmentation, in particular examining the role of UMAP (Uniform Manifold Approximation and Projection) as a technique for capturing representativeness. Although UMAP has been shown viable as a general purpose dimension reduction method in diverse areas, its role in deep learning-based medical segmentation has yet been extensively explored. Using the cardiac and prostate datasets in the Medical Segmentation Decathlon for validation, we found that a novel hybrid combination of Entropy-UMAP sampling technique achieved a statistically significant Dice score advantage over the random baseline ($3.2 \%$ for cardiac, $4.5 \%$ for prostate), and attained the highest Dice coefficient among the spectrum of 10 distinct active learning methodologies we examined. This provides preliminary evidence that there is an interesting synergy between entropy-based and UMAP methods when the former precedes the latter in a hybrid model of active learning.
The field of Radiation Oncology is uniquely positioned to benefit from the use of artificial intelligence to fully automate the creation of radiation treatment plans for cancer therapy. This time-consuming and specialized task combines patient imaging with organ and tumor segmentation to generate a 3D radiation dose distribution to meet clinical treatment goals, similar to voxel-level dense prediction. In this work, we propose Swin UNETR++, that contains a lightweight 3D Dual Cross-Attention (DCA) module to capture the intra and inter-volume relationships of each patient's unique anatomy, which fully convolutional neural networks lack. Our model was trained, validated, and tested on the Open Knowledge-Based Planning dataset. In addition to metrics of Dose Score $\overline{S_{\text{Dose}}}$ and DVH Score $\overline{S_{\text{DVH}}}$ that quantitatively measure the difference between the predicted and ground-truth 3D radiation dose distribution, we propose the qualitative metrics of average volume-wise acceptance rate $\overline{R_{\text{VA}}}$ and average patient-wise clinical acceptance rate $\overline{R_{\text{PA}}}$ to assess the clinical reliability of the predictions. Swin UNETR++ demonstrates near-state-of-the-art performance on validation and test dataset (validation: $\overline{S_{\text{DVH}}}$=1.492 Gy, $\overline{S_{\text{Dose}}}$=2.649 Gy, $\overline{R_{\text{VA}}}$=88.58%, $\overline{R_{\text{PA}}}$=100.0%; test: $\overline{S_{\text{DVH}}}$=1.634 Gy, $\overline{S_{\text{Dose}}}$=2.757 Gy, $\overline{R_{\text{VA}}}$=90.50%, $\overline{R_{\text{PA}}}$=98.0%), establishing a basis for future studies to translate 3D dose predictions into a deliverable treatment plan, facilitating full automation.